Does neutering your dog early raise the risk of cancer?

da Silva, Mantovani and Silva, at the Federal University of Uberlândia, searched the records of their university veterinary hospital from 2015 to 2024. Of 56,254 dogs seen, 313 were diagnosed with a mast cell tumor of the skin or the tissue under it, about 0.6%. The cases were compared with 638 tumor-free dogs from the same hospital, about two per case, matched by age group; dogs with a history of skin lumps were excluded. This is a case-control design: start with the dogs that have the disease, find comparable dogs that do not, and look backward for differences. The authors declare no competing interests.

The final model used 880 dogs with complete data (254 cases, 626 controls) and adjusted for age group, breed, body size, body condition and age at neutering together. Sex was not significantly associated with the tumor (unadjusted OR 1.29, 0.97–1.72) and was dropped from the model; males and females were not analysed separately, and no sex-by-neutering interaction was tested.

Two further findings matter for owners. Among the 62 dogs with enough follow-up for survival analysis, tumor grade (high grade: hazard ratio 2.93) and tumor size were associated with how long a dog lived after surgery; neuter status was not significantly associated with it (HR 0.79, 0.44–1.42). Needle-sample cytology caught 90% of high-grade tumors but also flagged many that were not (specificity 46%; agreement with histology κ 0.34), so a needle sample is a screen, not a verdict.

The authors list their own limitations: a retrospective design dependent on record accuracy, incomplete staging in some cases, possible selection bias and residual confounding, grading by several pathologists over the years without re-examination, and a small survival analysis. They did not measure luteinising hormone; they raise it only as a possible explanation in the discussion. The study received no specific grant funding.

"343% higher odds" is an odds ratio of 4.43. Most readers took it to mean "4.4 times as likely to get cancer." That is not what the study measured, for three reasons.

Odds are not chances. Odds compare dogs with a condition to dogs without it; chance compares dogs with the condition to all dogs. For a rare condition an odds ratio can approximate a risk ratio, provided the cases and controls were sampled in a way that represents the population. It is still a ratio, not a chance.

A case-control study cannot give your dog's chance. The researchers started from the dogs that had the tumor and chose tumor-free dogs to compare with them. That design can show which groups were over-represented among the cases. It cannot say how often the tumor happens in early-neutered dogs, or in any dog, because it never counted a whole population.

A link is not a cause. Dogs neutered early at a Brazilian referral hospital may differ from intact dogs in breed, size, weight, owner income and how often they see a vet. Any of those can change how often a tumor is found.

For scale: in English primary care, 0.27% of 168,636 dogs had a mast cell tumor diagnosis on record over six years of data collection (Shoop 2015). That is a period prevalence in a different country and population, not a baseline that the Brazilian odds ratio can be multiplied against, so this guide does not do that arithmetic. The point stands without it: the finding concerns one tumor type, in one hospital, and is a ratio of odds, not a chance.

Pyometra is an infection of the uterus driven by the hormone cycle. It is a surgical emergency and can be fatal. Jitpean and colleagues (2012) followed over 260,000 female dogs in a Swedish insurance database: 19% of intact females had pyometra by age 10, and 13% had mammary tumors; 30% had one or the other. In some breeds, more than 60% had one or both by that age (Leonberger 73%, Bernese Mountain Dog 69%, Rottweiler 65%). Pyometra depends on the hormones the ovaries produce, so removing the ovaries removes the drive behind it; leftover ovarian tissue can very rarely cause a "stump" pyometra. An ovary-sparing spay, which keeps the ovaries, prevents it only if every part of the uterus is removed (Kutzler 2020).

Castration removes the testicles, so it removes testicular tumors. These are rarely fatal in normally descended testicles. A retained testicle is a clearer reason to operate. Castration also prevents benign prostatic enlargement, which is common in old intact males but causes signs in few; prostate cancer is a different, rare disease, and the 2019 review notes castrated dogs have had a higher rate of it, not a lower one (Urfer 2019).

Mammary tumors

Figures such as 0.5%, 8% and 26% for dogs spayed before the first, second or later heats come from a 1969 study, and they are risks relative to intact females, not a spayed dog's chance of cancer. Beauvais, Cardwell and Brodbelt (2012) reviewed the literature systematically: of 13 studies, nine were at high risk of bias and four at moderate; one found a protective effect, two found none, and one reported "some protective effect" without numbers. They judged the evidence that spaying reduces mammary tumors, or that timing matters, "weak and not a sound basis for firm recommendations." WSAVA's 2024 guidelines say spaying reduces the risk, especially before the second heat, and also that spaying "should not be done solely for prevention of mammary tumours." A 2025 systematic review, searched in 2023, again found 13 eligible papers; six found no protective effect of early spaying, and the authors called for breed-specific studies with matched controls (Guirguis 2025). Mammary tumors are common in intact females (13% by age 10 in the Swedish data), so the benefit is plausible and poorly measured.

Behaviour and roaming in males

Neilson, Eckstein and Hart (1997) followed 57 adult male dogs castrated for a behaviour problem. For urine marking, mounting and roaming, 60% or more of dogs improved by at least half. For fear and for aggression toward strangers, castration had no significant effect; for other kinds of aggression, fewer than 35% improved by half. Age and how long the problem had lasted did not predict the result. WSAVA advises a behavioural assessment, and for males a reversible implant trial, before castrating for behaviour.

Lifespan

Hoffman, Creevy and Promislow (2013) analysed 70,574 deceased dogs in a North American veterinary hospital database, 40,139 of them with a cause of death. Neutered dogs lived longer. They died less often of infectious disease and trauma, and more often of cancer and immune-mediated disease. Urfer and Kaeberlein's 2019 review found the lifespan benefit "consistently demonstrated in females" and "inconsistent" in males, and noted two biases: neutering may be a marker of better care, and a dog neutered later has already lived to that age. One breed study points the other way: in VetCompass Australia records, Rottweilers neutered before one year (207 dogs) had an expected lifespan 1.5 years (males) and 1 year (females) shorter than 3,085 intact Rottweilers; (Joonè 2023).

Population control. Neutering prevents unplanned litters. The 2019 review found clear evidence of a population effect in free-roaming dogs, mainly from spaying females, and surprisingly little direct evidence in owned pet dogs. This guide is about an individual dog's health; the welfare case for preventing litters stands on its own.

The new study is one of nine. They do not agree, and the disagreement is the finding.

Across these, breed is the most consistent association: in the UK primary-care data Boxers, Pugs and Staffordshire Bull Terriers had higher adjusted odds than crossbreds (Labradors and Goldens had high prevalence but no significant adjusted association), and the new study adds American Pit Bull Terriers. Some datasets find more mast cell tumors in neutered dogs, mostly females. Others find fewer. The differences likely reflect how "neutered" was recorded, who the controls were, and which breeds dominate each population.

Bone cancer

Cooley and colleagues (2002) followed 683 Rottweilers. Dogs neutered before one year had about a one-in-four lifetime risk of bone sarcoma and were more likely to develop it than intact dogs (relative risk 3.8 in males, 3.1 in females). The shorter a dog's lifetime hormone exposure, the higher the rate, independent of height or weight. Bone sarcoma affected 12.6% of the whole cohort.

Hemangiosarcoma and lymphoma

In 759 Golden Retrievers at UC Davis, hemangiosarcoma occurred in about 8% of females neutered at 12 months or later, four times the rate in intact or early-neutered females. Lymphoma occurred in almost 10% of early-neutered males, three times the intact rate (Torres de la Riva 2013). Vizslas neutered at any age had higher odds of lymphoma; for hemangiosarcoma the pattern depended on age at neutering and sex (Zink 2014). The Labrador comparison found much smaller effects: female Labradors showed only a slight increase in cancers with neutering, against a three- to four-fold increase in female Goldens (Hart 2014).

Joint disease

Sex hormones help signal when growth plates close. Neutering before maturity can leave a dog slightly taller with different limb angles. In the Golden Retriever series there were no cruciate ligament tears in intact dogs, against 5% of early-neutered males and 8% of early-neutered females; early-neutered males had twice the hip dysplasia. In Labradors, dogs neutered before 6 months had one or more joint disorders at twice the 5% rate of intact dogs; in Goldens, at four to five times it (Hart 2014). Across 35 breeds, small breeds showed no increase in joint disorders with neutering (Hart 2020). In mixed-breed dogs, neutering before one year was associated with joint disorders, commonly at three times the intact rate, in the three weight classes of 20 kg or more, and with no increase below 20 kg (Hart 2020b). One prospective study now exists: Moxon and colleagues (2025) followed 306 Labrador and Golden Retriever crossbreed bitches in an assistance-dog programme, spayed either before puberty (155) or after (151). Cruciate ligament disease occurred in 11 of the prepubertal group and 1 of the postpubertal group, and the prepubertal group were less likely to stay free of osteoarthritis; urinary incontinence did not differ (1 vs 6 cases).

Urinary incontinence

Spayed females are more prone to hormone-responsive urinary incontinence. Pegram and colleagues (2024) used VetCompass records and a "target trial emulation" design, which weights observational data to mimic a randomised trial. Bitches spayed at 7 to 18 months had 0.80 times the odds of early-onset incontinence (diagnosed before 8.5 years) of those spayed at 3 to under 7 months (95% CI 0.54–0.97; 612 early, 888 later). The authors advise delaying spaying to 7 months or later "unless other major reasons justify earlier surgery." WSAVA notes the risk is greater in bitches spayed before puberty whose adult weight exceeds 25 kg.

Weight

Food intake rises after neutering, and neutered dogs are over-represented among overweight dogs in practice data (Urfer 2019). Of everything on this list it is the most manageable. We found no primary figure we could cite for how much to cut food after surgery, so this guide gives none; body condition checks and your vet's advice do the job.

The hormone theory

Removing the gonads removes the feedback that keeps luteinising hormone (LH) in check, so LH stays high. LH receptors have been found in some non-reproductive tissues and tumors, including canine mast cell tumors, lymphoma, hemangiosarcoma, osteosarcoma and cruciate ligaments (Kutzler 2020). It is a plausible mechanism. No study has shown that high LH causes any of these diseases in dogs, and the new study did not measure it.

Breed is the most consistent factor for mast cell tumors across studies. In 168,636 UK dogs, Boxers had 10.7 times the adjusted odds of crossbreds, Pugs 10.0 and Staffordshire Bull Terriers 4.2, while German Shepherds, Border Collies and several spaniels and terriers had lower odds; Labradors and Goldens had high prevalence without a significant adjusted association (Shoop 2015). The UK pathology registry found odds up to 6.8 for bulldog-type breeds and retrievers (Rodríguez 2026). The new study adds American Pit Bull Terriers (OR 7.46, from 26 cases and 3 controls). Across countries and designs, the breed effect is the steadiest finding in this literature.

Size matters for joints. The joint signal with early neutering appears in larger breeds and in mixed breeds of 20 kg or more, and not below.

Sex matters, and the risks differ. Females get the pyometra benefit and carry the incontinence risk; several of the mast cell datasets find the neuter-linked increase mainly in females; the lifespan benefit is clearer in females. Males get the behaviour and testicular benefits.

Breed-by-breed guidance exists, from one group. The UC Davis team publishes suggested neuter ages for 40 breeds and five mixed-breed weight classes, built from their own hospital's records (Hart 2020, 2023, 2024). For female Golden Retrievers they suggest leaving intact or spaying after one year while staying alert for cancer; for Boxers, delaying past two years. These are reasonable starting points from one retrospective dataset, not rules.

Ovary-sparing spay removes the uterus and keeps the ovaries. The dog cannot have litters and, if the whole uterus is removed, cannot get pyometra. She still cycles, attracts males and keeps the hormonal mammary risk. A 2026 review says long-term outcome studies are needed and that in practice it is mostly used to delay full spaying (De Cramer 2026).

Vasectomy prevents fathering puppies and keeps testosterone, so it also keeps roaming, marking and mounting, and prostate and testicular disease risk (Kutzler 2020).

Deslorelin implant, a reversible GnRH-agonist "chemical castration", is licensed in some countries for temporary infertility in male dogs. WSAVA recommends it as a trial before irreversible castration for behaviour. Onset and duration vary between dogs; testosterone can rise briefly after the implant goes in before it falls, so infertility cannot be assumed at once, and recovery after removal is also variable (Stempel 2020, 2022).

One comparison exists. Zink, Delgado and Stella (2023) surveyed owners of 6,018 dogs, among them 58 vasectomised males and 159 females with an ovary-sparing spay. Longer exposure to gonadal hormones, whatever the procedure, was associated with lower odds of general health problems and problem behaviours. The groups are small, the data are owner-reported and retrospective, and owners who choose these operations may differ in other ways.

Waiting is itself an option: managing heats or male behaviour, preventing pregnancy, and watching for pyometra for longer.

A guideline records expert consensus. It is not itself a trial result, and each recommendation above rests on the observational evidence described in sections 05 and 06.